A major lesson from the COVID-19 pandemic is the need to decolonize transnational governance so that the world is better able to handle both future and current global crises.
Only 15.8% of the population in low-income countries is double-dosed. Vaccine hoarding by high income countries is to blame.
Fourth COVID shots have been approved for over-30s, a necessary step to help protect Australians this winter. But we should be doing more.
On the horizon: A new omicron-focused version of the Moderna vaccine that may offer longer protection and a stronger immune response.
With COVID-19 shots finally available for infants and preschoolers, knowing how to combat misinformation on social media and elsewhere could be more important than ever.
To help people make informed decisions about ongoing COVID-19 risks, public health messaging needs to adapt as the pandemic evolves, just as immune systems adapt to new viruses and variants.
Waiving patent rights on COVID-19 vaccines and drugs is still crucial to ensure access globally, but the waiver on the table at the June World Trade Organization meeting doesn’t do the job.
Achieving herd immunity via vaccination was always going to be a hard ask. Now it’s mathematically impossible.
Understanding the depth of vaccine hesitancy, and the drivers behind the lack of take-up is critical to preventing further deaths, infections, and continuing harm to the economy.
An inhaled COVID-19 vaccine would go directly to where the body would use it: the mucosal surface of the airways. This could mean less waste and more benefit, lower costs and reduced side-effects.
The COVID-19 vaccines continue to be effective against severe illness leading to hospitalization and death in all age groups, including children ages 5 to 11.
Boosters and vaccinating children mean we’re relying on two pharmaceutical companies to supply Australia’s COVID vaccines. That needs to change.
The COVID-19 mRNA vaccines put nanomedicine in the spotlight as a potential way to treat diseases like cancer and HIV. While the field isn’t there yet, better design could help fulfill its promise.
Studies show if medical staff talk about potential side effects in negative terms, the patient’s experience can worsen. We need to consider this ‘nocebo’ effect when talking about COVID vaccinations.
New data on the second booster suggests the older you are, the more you need it.
At this point it’s pragmatic to integrate COVID-19 management into routine health practices.
Many COVID-19 vaccination campaigns encourage doctors to serve as a trusted source of vaccine information. But certain vaccine-hesitant providers may stymie these efforts.
Moderna will ask the FDA to allow emergency use for its vaccine in children as young as 6 months, a step many parents have been anticipating.
Evusheld is an antibody drug from AstraZeneca intended to help prevent COVID-19 infection for immunocompromised and other vulnerable patients.
Vaccine passports became one of the most divisive issues of the COVID-19 pandemic. These policies were affected not only by public opinion but by new variants and changing goals for herd immunity.